Global Sanger Sequencing Service Market Analysis and Forecast 2024-2030

Global Sanger Sequencing Service Market Analysis and Forecast 2024-2030


Summary

DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.

According to APO Research, The global Sanger Sequencing Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Sanger Sequencing Service is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Sanger Sequencing Service is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Sanger Sequencing Service is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Sanger Sequencing Service is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Sanger Sequencing Service include Source BioScience, GenScript, Thermofisher, Nucleics, GenHunter Corporation, LGC Limited, SciGenom Labs, Fasteris SA and CeMIA SA, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes

This report presents an overview of global market for Sanger Sequencing Service, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Sanger Sequencing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Sanger Sequencing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sanger Sequencing Service revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Sanger Sequencing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Sanger Sequencing Service revenue, projected growth trends, production technology, application and end-user industry.

Sanger Sequencing Service segment by Company

Source BioScience
GenScript
Thermofisher
Nucleics
GenHunter Corporation
LGC Limited
SciGenom Labs
Fasteris SA
CeMIA SA
Microsynth AG
QuintaraBio
Eurofins
Genewiz
Sanger Sequencing Service segment by Type

Plasmid DNA
PCR Amplicons
Others
Sanger Sequencing Service segment by Application

Bioscience Companies
Hospitals
Institutions
Sanger Sequencing Service segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sanger Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sanger Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sanger Sequencing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Sanger Sequencing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Sanger Sequencing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sanger Sequencing Service revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Sanger Sequencing Service Market by Type
1.2.1 Global Sanger Sequencing Service Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Plasmid DNA
1.2.3 PCR Amplicons
1.2.4 Others
1.3 Sanger Sequencing Service Market by Application
1.3.1 Global Sanger Sequencing Service Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Bioscience Companies
1.3.3 Hospitals
1.3.4 Institutions
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Sanger Sequencing Service Market Dynamics
2.1 Sanger Sequencing Service Industry Trends
2.2 Sanger Sequencing Service Industry Drivers
2.3 Sanger Sequencing Service Industry Opportunities and Challenges
2.4 Sanger Sequencing Service Industry Restraints
3 Global Growth Perspective
3.1 Global Sanger Sequencing Service Market Perspective (2019-2030)
3.2 Global Sanger Sequencing Service Growth Trends by Region
3.2.1 Global Sanger Sequencing Service Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Sanger Sequencing Service Market Size by Region (2019-2024)
3.2.3 Global Sanger Sequencing Service Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Sanger Sequencing Service Revenue by Players
4.1.1 Global Sanger Sequencing Service Revenue by Players (2019-2024)
4.1.2 Global Sanger Sequencing Service Revenue Market Share by Players (2019-2024)
4.1.3 Global Sanger Sequencing Service Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Sanger Sequencing Service Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Sanger Sequencing Service Key Players Headquarters & Area Served
4.4 Global Sanger Sequencing Service Players, Product Type & Application
4.5 Global Sanger Sequencing Service Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Sanger Sequencing Service Market CR5 and HHI
4.6.2 Global Top 5 and 10 Sanger Sequencing Service Players Market Share by Revenue in 2023
4.6.3 2023 Sanger Sequencing Service Tier 1, Tier 2, and Tier 3
5 Sanger Sequencing Service Market Size by Type
5.1 Global Sanger Sequencing Service Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Sanger Sequencing Service Revenue by Type (2019-2030)
5.3 Global Sanger Sequencing Service Revenue Market Share by Type (2019-2030)
6 Sanger Sequencing Service Market Size by Application
6.1 Global Sanger Sequencing Service Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Sanger Sequencing Service Revenue by Application (2019-2030)
6.3 Global Sanger Sequencing Service Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Source BioScience
7.1.1 Source BioScience Comapny Information
7.1.2 Source BioScience Business Overview
7.1.3 Source BioScience Sanger Sequencing Service Revenue and Gross Margin (2019-2024)
7.1.4 Source BioScience Sanger Sequencing Service Product Portfolio
7.1.5 Source BioScience Recent Developments
7.2 GenScript
7.2.1 GenScript Comapny Information
7.2.2 GenScript Business Overview
7.2.3 GenScript Sanger Sequencing Service Revenue and Gross Margin (2019-2024)
7.2.4 GenScript Sanger Sequencing Service Product Portfolio
7.2.5 GenScript Recent Developments
7.3 Thermofisher
7.3.1 Thermofisher Comapny Information
7.3.2 Thermofisher Business Overview
7.3.3 Thermofisher Sanger Sequencing Service Revenue and Gross Margin (2019-2024)
7.3.4 Thermofisher Sanger Sequencing Service Product Portfolio
7.3.5 Thermofisher Recent Developments
7.4 Nucleics
7.4.1 Nucleics Comapny Information
7.4.2 Nucleics Business Overview
7.4.3 Nucleics Sanger Sequencing Service Revenue and Gross Margin (2019-2024)
7.4.4 Nucleics Sanger Sequencing Service Product Portfolio
7.4.5 Nucleics Recent Developments
7.5 GenHunter Corporation
7.5.1 GenHunter Corporation Comapny Information
7.5.2 GenHunter Corporation Business Overview
7.5.3 GenHunter Corporation Sanger Sequencing Service Revenue and Gross Margin (2019-2024)
7.5.4 GenHunter Corporation Sanger Sequencing Service Product Portfolio
7.5.5 GenHunter Corporation Recent Developments
7.6 LGC Limited
7.6.1 LGC Limited Comapny Information
7.6.2 LGC Limited Business Overview
7.6.3 LGC Limited Sanger Sequencing Service Revenue and Gross Margin (2019-2024)
7.6.4 LGC Limited Sanger Sequencing Service Product Portfolio
7.6.5 LGC Limited Recent Developments
7.7 SciGenom Labs
7.7.1 SciGenom Labs Comapny Information
7.7.2 SciGenom Labs Business Overview
7.7.3 SciGenom Labs Sanger Sequencing Service Revenue and Gross Margin (2019-2024)
7.7.4 SciGenom Labs Sanger Sequencing Service Product Portfolio
7.7.5 SciGenom Labs Recent Developments
7.8 Fasteris SA
7.8.1 Fasteris SA Comapny Information
7.8.2 Fasteris SA Business Overview
7.8.3 Fasteris SA Sanger Sequencing Service Revenue and Gross Margin (2019-2024)
7.8.4 Fasteris SA Sanger Sequencing Service Product Portfolio
7.8.5 Fasteris SA Recent Developments
7.9 CeMIA SA
7.9.1 CeMIA SA Comapny Information
7.9.2 CeMIA SA Business Overview
7.9.3 CeMIA SA Sanger Sequencing Service Revenue and Gross Margin (2019-2024)
7.9.4 CeMIA SA Sanger Sequencing Service Product Portfolio
7.9.5 CeMIA SA Recent Developments
7.10 Microsynth AG
7.10.1 Microsynth AG Comapny Information
7.10.2 Microsynth AG Business Overview
7.10.3 Microsynth AG Sanger Sequencing Service Revenue and Gross Margin (2019-2024)
7.10.4 Microsynth AG Sanger Sequencing Service Product Portfolio
7.10.5 Microsynth AG Recent Developments
7.11 QuintaraBio
7.11.1 QuintaraBio Comapny Information
7.11.2 QuintaraBio Business Overview
7.11.3 QuintaraBio Sanger Sequencing Service Revenue and Gross Margin (2019-2024)
7.11.4 QuintaraBio Sanger Sequencing Service Product Portfolio
7.11.5 QuintaraBio Recent Developments
7.12 Eurofins
7.12.1 Eurofins Comapny Information
7.12.2 Eurofins Business Overview
7.12.3 Eurofins Sanger Sequencing Service Revenue and Gross Margin (2019-2024)
7.12.4 Eurofins Sanger Sequencing Service Product Portfolio
7.12.5 Eurofins Recent Developments
7.13 Genewiz
7.13.1 Genewiz Comapny Information
7.13.2 Genewiz Business Overview
7.13.3 Genewiz Sanger Sequencing Service Revenue and Gross Margin (2019-2024)
7.13.4 Genewiz Sanger Sequencing Service Product Portfolio
7.13.5 Genewiz Recent Developments
8 North America
8.1 North America Sanger Sequencing Service Revenue (2019-2030)
8.2 North America Sanger Sequencing Service Revenue by Type (2019-2030)
8.2.1 North America Sanger Sequencing Service Revenue by Type (2019-2024)
8.2.2 North America Sanger Sequencing Service Revenue by Type (2025-2030)
8.3 North America Sanger Sequencing Service Revenue Share by Type (2019-2030)
8.4 North America Sanger Sequencing Service Revenue by Application (2019-2030)
8.4.1 North America Sanger Sequencing Service Revenue by Application (2019-2024)
8.4.2 North America Sanger Sequencing Service Revenue by Application (2025-2030)
8.5 North America Sanger Sequencing Service Revenue Share by Application (2019-2030)
8.6 North America Sanger Sequencing Service Revenue by Country
8.6.1 North America Sanger Sequencing Service Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Sanger Sequencing Service Revenue by Country (2019-2024)
8.6.3 North America Sanger Sequencing Service Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 Europe
9.1 Europe Sanger Sequencing Service Revenue (2019-2030)
9.2 Europe Sanger Sequencing Service Revenue by Type (2019-2030)
9.2.1 Europe Sanger Sequencing Service Revenue by Type (2019-2024)
9.2.2 Europe Sanger Sequencing Service Revenue by Type (2025-2030)
9.3 Europe Sanger Sequencing Service Revenue Share by Type (2019-2030)
9.4 Europe Sanger Sequencing Service Revenue by Application (2019-2030)
9.4.1 Europe Sanger Sequencing Service Revenue by Application (2019-2024)
9.4.2 Europe Sanger Sequencing Service Revenue by Application (2025-2030)
9.5 Europe Sanger Sequencing Service Revenue Share by Application (2019-2030)
9.6 Europe Sanger Sequencing Service Revenue by Country
9.6.1 Europe Sanger Sequencing Service Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Sanger Sequencing Service Revenue by Country (2019-2024)
9.6.3 Europe Sanger Sequencing Service Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Sanger Sequencing Service Revenue (2019-2030)
10.2 China Sanger Sequencing Service Revenue by Type (2019-2030)
10.2.1 China Sanger Sequencing Service Revenue by Type (2019-2024)
10.2.2 China Sanger Sequencing Service Revenue by Type (2025-2030)
10.3 China Sanger Sequencing Service Revenue Share by Type (2019-2030)
10.4 China Sanger Sequencing Service Revenue by Application (2019-2030)
10.4.1 China Sanger Sequencing Service Revenue by Application (2019-2024)
10.4.2 China Sanger Sequencing Service Revenue by Application (2025-2030)
10.5 China Sanger Sequencing Service Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Sanger Sequencing Service Revenue (2019-2030)
11.2 Asia Sanger Sequencing Service Revenue by Type (2019-2030)
11.2.1 Asia Sanger Sequencing Service Revenue by Type (2019-2024)
11.2.2 Asia Sanger Sequencing Service Revenue by Type (2025-2030)
11.3 Asia Sanger Sequencing Service Revenue Share by Type (2019-2030)
11.4 Asia Sanger Sequencing Service Revenue by Application (2019-2030)
11.4.1 Asia Sanger Sequencing Service Revenue by Application (2019-2024)
11.4.2 Asia Sanger Sequencing Service Revenue by Application (2025-2030)
11.5 Asia Sanger Sequencing Service Revenue Share by Application (2019-2030)
11.6 Asia Sanger Sequencing Service Revenue by Country
11.6.1 Asia Sanger Sequencing Service Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Sanger Sequencing Service Revenue by Country (2019-2024)
11.6.3 Asia Sanger Sequencing Service Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Sanger Sequencing Service Revenue (2019-2030)
12.2 MEALA Sanger Sequencing Service Revenue by Type (2019-2030)
12.2.1 MEALA Sanger Sequencing Service Revenue by Type (2019-2024)
12.2.2 MEALA Sanger Sequencing Service Revenue by Type (2025-2030)
12.3 MEALA Sanger Sequencing Service Revenue Share by Type (2019-2030)
12.4 MEALA Sanger Sequencing Service Revenue by Application (2019-2030)
12.4.1 MEALA Sanger Sequencing Service Revenue by Application (2019-2024)
12.4.2 MEALA Sanger Sequencing Service Revenue by Application (2025-2030)
12.5 MEALA Sanger Sequencing Service Revenue Share by Application (2019-2030)
12.6 MEALA Sanger Sequencing Service Revenue by Country
12.6.1 MEALA Sanger Sequencing Service Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Sanger Sequencing Service Revenue by Country (2019-2024)
12.6.3 MEALA Sanger Sequencing Service Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings